M2ES 7.5mg

DRUG2 trials

Sponsors

Protgen Ltd

Conditions

Advanced Solid TumorsPancreatic Cancer

Phase 1

Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer

Protgen LtdPancreatic Cancer

Start: 2010-06-30End: 2011-12-31Target: 21Updated: 2010-10-19

Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors

Protgen LtdAdvanced Solid Tumors

Start: 2009-09-30End: 2011-06-30Target: 24Updated: 2010-10-21